| Dr Glenn Coullard, OD | |
|
2421 Church St, Zachary, LA 70791-2710 | |
| (225) 654-1061 | |
| (225) 654-0791 |
| Full Name | Dr Glenn Coullard |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 57 Years |
| Location | 2421 Church St, Zachary, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346209236 | NPI | - | NPPES |
| 1135411 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 683333T (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| C J Pollet Od Inc | 5294972824 | 3 |
News Archive
NeuroMetrix, Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and twelve months ended December 31, 2012.
One of the scourges of infections in hospitals – biofilms formed by bacteria that stick to each other on living tissue and medical instruments, making them harder to remove – can be tricked into dispersing with the targeted application of nanoparticles and heat, researchers have found.
A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society, have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson's disease, especially in its early stages.
Medicare, an indispensable safety net, is fiscally unsustainable in the long term, yet it may be politically untouchable, The Center for Public Integrity reports in the first of a multipart series.
Using a combination of computational and experimental techniques, a research team at the University of Massachusetts Amherst led by molecular biologist Lila Gierasch has demystified the pathway of interdomain communication in a family of proteins known as Hsp70s - a top target of dozens of research laboratories trying to develop new anti-cancer drugs, antibiotics and treatments for Alzheimer's and Parkinson's diseases.
› Verified 8 days ago
| Provider Name | Vision Optique Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1134152408 PECOS PAC ID: 4789670704 Enrollment ID: O20040423000569 |
News Archive
NeuroMetrix, Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and twelve months ended December 31, 2012.
One of the scourges of infections in hospitals – biofilms formed by bacteria that stick to each other on living tissue and medical instruments, making them harder to remove – can be tricked into dispersing with the targeted application of nanoparticles and heat, researchers have found.
A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society, have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson's disease, especially in its early stages.
Medicare, an indispensable safety net, is fiscally unsustainable in the long term, yet it may be politically untouchable, The Center for Public Integrity reports in the first of a multipart series.
Using a combination of computational and experimental techniques, a research team at the University of Massachusetts Amherst led by molecular biologist Lila Gierasch has demystified the pathway of interdomain communication in a family of proteins known as Hsp70s - a top target of dozens of research laboratories trying to develop new anti-cancer drugs, antibiotics and treatments for Alzheimer's and Parkinson's diseases.
› Verified 8 days ago
| Provider Name | C J Pollet Od Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1194091710 PECOS PAC ID: 5294972824 Enrollment ID: O20180123001812 |
News Archive
NeuroMetrix, Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and twelve months ended December 31, 2012.
One of the scourges of infections in hospitals – biofilms formed by bacteria that stick to each other on living tissue and medical instruments, making them harder to remove – can be tricked into dispersing with the targeted application of nanoparticles and heat, researchers have found.
A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society, have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson's disease, especially in its early stages.
Medicare, an indispensable safety net, is fiscally unsustainable in the long term, yet it may be politically untouchable, The Center for Public Integrity reports in the first of a multipart series.
Using a combination of computational and experimental techniques, a research team at the University of Massachusetts Amherst led by molecular biologist Lila Gierasch has demystified the pathway of interdomain communication in a family of proteins known as Hsp70s - a top target of dozens of research laboratories trying to develop new anti-cancer drugs, antibiotics and treatments for Alzheimer's and Parkinson's diseases.
› Verified 8 days ago
| Provider Name | Dr Glenn M Coullard |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1972110401 PECOS PAC ID: 9436560513 Enrollment ID: O20201120000931 |
News Archive
NeuroMetrix, Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and twelve months ended December 31, 2012.
One of the scourges of infections in hospitals – biofilms formed by bacteria that stick to each other on living tissue and medical instruments, making them harder to remove – can be tricked into dispersing with the targeted application of nanoparticles and heat, researchers have found.
A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society, have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson's disease, especially in its early stages.
Medicare, an indispensable safety net, is fiscally unsustainable in the long term, yet it may be politically untouchable, The Center for Public Integrity reports in the first of a multipart series.
Using a combination of computational and experimental techniques, a research team at the University of Massachusetts Amherst led by molecular biologist Lila Gierasch has demystified the pathway of interdomain communication in a family of proteins known as Hsp70s - a top target of dozens of research laboratories trying to develop new anti-cancer drugs, antibiotics and treatments for Alzheimer's and Parkinson's diseases.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glenn Coullard, OD 2421 Church St, Zachary, LA 70791-2710 Ph: (225) 654-1061 | Dr Glenn Coullard, OD 2421 Church St, Zachary, LA 70791-2710 Ph: (225) 654-1061 |
News Archive
NeuroMetrix, Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, today reported business and financial highlights for the quarter and twelve months ended December 31, 2012.
One of the scourges of infections in hospitals – biofilms formed by bacteria that stick to each other on living tissue and medical instruments, making them harder to remove – can be tricked into dispersing with the targeted application of nanoparticles and heat, researchers have found.
A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society, have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson's disease, especially in its early stages.
Medicare, an indispensable safety net, is fiscally unsustainable in the long term, yet it may be politically untouchable, The Center for Public Integrity reports in the first of a multipart series.
Using a combination of computational and experimental techniques, a research team at the University of Massachusetts Amherst led by molecular biologist Lila Gierasch has demystified the pathway of interdomain communication in a family of proteins known as Hsp70s - a top target of dozens of research laboratories trying to develop new anti-cancer drugs, antibiotics and treatments for Alzheimer's and Parkinson's diseases.
› Verified 8 days ago
Belanger Eye Care,llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5801 Main St, Zachary, LA 70791 Phone: 225-328-2499 Fax: 225-654-3047 | |
Dr. Chad Michael Belanger, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 5801 Main St, Zachary, LA 70791 Phone: 225-654-1176 Fax: 225-654-3047 | |
Michael Bradford Jelks, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2421 Church St, Zachary, LA 70791 Phone: 225-654-1061 Fax: 225-654-0791 | |
Dr. Phong Quoc Tran, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 20103 Old Scenic Hwy Ste 2b, Zachary, LA 70791 Phone: 225-570-2753 Fax: 225-570-2758 | |
Regional Eye Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2421 Church St, Zachary, LA 70791 Phone: 225-654-1061 Fax: 225-654-0791 | |
Toomey Belanger Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 20103 Old Scenic Hwy, Building #2, Suite B, Zachary, LA 70791 Phone: 225-570-2753 Fax: 225-570-2758 |